Teledentistry provider Dentulu has partnered with Viome to integrate its CancerDetect salivary diagnostic test into Dentulu’s U.S. platform.
The at-home, noninvasive test uses RNA sequencing and AI to detect the early signs of oral and throat cancers, including squamous cell carcinomas.
Patients collect saliva samples at home, which are analyzed by Viome’s AI models. Dentulu’s dental professionals review the results, provide guidance, and ensure patients with concerning findings are referred for care.
